Skip to content
NASDAQ · PHARMACEUTICAL PREPARATIONS · SMALL CAP

Eledon Pharmaceuticals, Inc. ELDN

14 fiscal years on record · USD · FY2025 reported · SEC filings only
$-45.6M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

·
Revenue, FY2025 · full 14-year series below
Revenue $M Net income $M
FY2016 · Revenue 0.0 · Net income -5.7
-20M-40M
201220152018202120242025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
ROE
FY2025 · ROE -63.6%
-50%-100%
201220182025
Three returns, three denominators.
Return on capital employedNot available: we don't have a clean operating profit figure for this period.

Each USD of equity lost 64 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2016 · FCF -4.9
-15M-30M
201220182025

Total assetsUSD 169.0M
EquityUSD 81.1M
CashUSD 22.8M
Current ratio7.40×

Equity funds 48% of total assets.

The 14-year record

14 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
ELDN, 14-year financial record
Metric 20252024202320222021202020192018201720162015201420132012
Revenue $B◌◌◌◌◌◌◌◌◌0.00.00.00.00.0
Operating income $B−0.0−0.0−0.1−0.1−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B◌◌◌◌◌◌◌◌◌−0.0−0.0−0.0−0.0−0.0
Income tax $B0.00.00.00.0−0.0−0.0◌◌◌0.00.00.00.0◌
Net income $B−0.0−0.0−0.1−0.1−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B◌◌◌◌◌◌◌◌◌−0.0−0.0−0.0−0.0−0.0
EPS, diluted $−0.52◌◌−6.16−2.33−15.72−24.42−1.56−2.30−2.46−2.01−3.60−38.02−31.09
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend——————————————
ROE %−63.6——−93.7−19.5−22.8−133.7−82.9——−84.8———
Shares out B0.080.060.020.010.010.020.010.010.010.000.020.020.00◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 2 failures in 52 reconciliationsAUDITED

Reconciled in 12 of the 14 fiscal years we could check. 12 checks were skipped: the balance sheet is not tagged before 2013. Five checks were skipped: EPS is not tagged before 2012.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency2 failures
ActivityPharmaceutical Preparations
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2012

Share this section

Download image